METLIFE INC - Common Stock, par value $.01 per share (MET)

Historical Holders from Q1 2014 to Q3 2025

Symbol
MET on NYSE
Type / Class
Equity / Common Stock, par value $.01 per share
Shares outstanding
659M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
480M
Holdings value
$39.5B
% of all portfolios
0.021%
Grand Portfolio weight change
-0.001%
Number of holders
1343
Number of buys
584
Number of sells
-642
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of METLIFE INC - Common Stock, par value $.01 per share (MET)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BOARD OF DIRECTORS OF METLIFE INC 16.17% -0.69% $8.78B -$139M 107M -1.56% Board of Directors of MetLife, Inc., as an entity 06 Nov 2025
VANGUARD GROUP INC 9.73% $5.33B 64.7M The Vanguard Group 30 Sep 2025

Institutional Holders of METLIFE INC - Common Stock, par value $.01 per share (MET)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 480M $39.5B -$498M $82.37 1,343
2025 Q2 488M $39.3B +$200M $80.42 1,400
2025 Q1 486M $39B -$1.44B $80.29 1,390
2024 Q4 504M $41.2B -$317M $81.88 1,388
2024 Q3 508M $41.9B -$1.03B $82.48 1,306
2024 Q2 519M $36.4B -$267M $70.19 1,293
2024 Q1 523M $38.8B -$952M $74.11 1,266
2023 Q4 537M $35.5B -$757M $66.13 1,259
2023 Q3 547M $34.4B -$531M $62.91 1,176
2023 Q2 553M $31.3B -$708M $56.53 1,162
2023 Q1 566M $32.8B -$458M $57.94 1,196
2022 Q4 571M $41.3B -$603M $72.37 1,299
2022 Q3 578M $35.1B -$332M $60.78 1,174
2022 Q2 583M $36.6B -$1.02B $62.79 1,181
2022 Q1 601M $42.3B -$705M $70.28 1,208
2021 Q4 612M $38.3B -$905M $62.49 1,171
2021 Q3 626M $38.6B -$1.23B $61.73 1,092
2021 Q2 647M $38.7B -$1.34B $59.85 1,108
2021 Q1 668M $40.6B -$11.1M $60.79 1,060
2020 Q4 669M $31.4B -$84.1M $46.95 1,025
2020 Q3 676M $25.1B -$776M $37.17 950
2020 Q2 690M $25.2B +$281M $36.52 967
2020 Q1 683M $20.9B -$398M $30.57 938
2019 Q4 687M $35B -$48.5M $50.97 1,092
2019 Q3 690M $32.5B -$1.22B $47.16 1,029
2019 Q2 714M $35.5B -$364M $49.67 1,025
2019 Q1 727M $30.9B -$192M $42.57 1,031
2018 Q4 732M $30B -$1.44B $41.06 995
2018 Q3 765M $35.7B -$527M $46.72 995
2018 Q2 777M $33.9B -$771M $43.60 1,017
2018 Q1 794M $36.4B -$655M $45.89 1,017
2017 Q4 808M $40.9B -$169M $50.56 1,076
2017 Q3 810M $42B +$766M $51.95 971
2017 Q2 795M $43.7B -$554M $54.94 1,019
2017 Q1 806M $42.6B +$2.05B $52.82 1,039
2016 Q4 833M $44.9B +$201M $53.89 1,027
2016 Q3 828M $36.7B +$124M $44.43 946
2016 Q2 825M $32.9B +$117M $39.83 970
2016 Q1 821M $36.1B -$549M $43.94 954
2015 Q4 831M $40.1B -$580M $48.21 975
2015 Q3 843M $39.7B -$368M $47.15 952
2015 Q2 853M $47.7B +$763M $55.99 964
2015 Q1 835M $42.2B -$1B $50.55 927
2014 Q4 855M $46.2B +$1.76B $54.09 947
2014 Q3 820M $44B -$1.64B $53.72 881
2014 Q2 849M $47.2B +$1.85B $55.56 895
2014 Q1 816M $43.1B +$317M $52.80 903